Last reviewed · How we verify

NCT06330155

A Genetic Study for Alzheimer Dementia: Case-control Study

Not yet recruiting Last updated 4 April 2024
What this trial tests

trial in Alzheimer Dementia (AD) in 20 participants. Not yet recruiting.

Timeline
26 March 2024
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorMinYoung Kim, MD, PhD
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment20
Start date26 March 2024
Primary completion31 December 2026
Estimated completion31 December 2026

Conditions studied

Sponsor

MinYoung Kim, MD, PhD

Who can join

60 and older, any sex, with Alzheimer Dementia (AD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to find out the difference in genetic test results between Alzheimer's dementia patients and healthy subjects. The investigators want to identify genes that are importantly related to Alzheimer's dementia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Alzheimer Dementia (AD)

Currently open trials in the same condition.

Other MinYoung Kim, MD, PhD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06330155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing